#40 - Three Breakthroughs: Brain-Computer Interfaces, Advanced Neural Networks, and Ozempic Trade Update

In the latest episode of the AV Tech Optimist podcast, 'Three Breakthroughs' segment, Mike Collins and Mike Peri explore three transformative technologies set to reshape our health. They delve into Neuralink's brain-machine interfaces, which promise to revolutionize neurological treatments and enhance cognitive capabilities. The discussion also covers advancements in artificial intelligence through deep neural networks, pushing the boundaries of machine learning. Additionally, they discuss the widespread impact of GLP-1 drugs on managing diabetes and obesity, with significant implications for public health. Tune in to learn how these innovations are at the forefront of medical and technological progress.

To Learn More:

Speakers:

Chapters:
  • (00:00) - Intro
  • (04:55) - Brain-Computer Interfaces
  • (21:20) - Advanced Neural Networks
  • (32:46) - Ozempic Trade Update
  • (49:14) - Closing



Legal Disclosure:

Creators and Guests

Mike Collins
Host
Mike Collins
CEO and Co-Founder at Alumni Ventures
Jeannie Masters
Producer
Jeannie Masters
SVP of Communication at Alumni Ventures
Keith Murphy
Producer
Keith Murphy
Director, Video Programs at Alumni Ventures
person
Producer
Kirsten Bannan
Social Media Manager at Alumni Ventures
Shail Highbloom
Producer
Shail Highbloom
Platform (CEO Services) at Alumni Ventures
#40 - Three Breakthroughs: Brain-Computer Interfaces, Advanced Neural Networks, and Ozempic Trade Update
Broadcast by